Related Experiment Videos
Development of hypertension in IgA nephropathy as a marker of a poor prognosis
S Rekola1, A Bergstrand, H Bucht
1Department of Renal Medicine, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
Insights
Hypertension significantly impacts IgA nephropathy prognosis. Most patients develop high blood pressure within 10 years, leading to poor kidney survival rates and disease progression.
Area of Science:
- Nephrology
- Clinical Medicine
- Hypertension Research
Background:
- Immunoglobulin A (IgA) nephropathy is a common cause of glomerulonephritis.
- Hypertension is a known complication and potential driver of IgA nephropathy progression.
Purpose of the Study:
- To investigate the prevalence and prognostic significance of hypertension in IgA nephropathy.
- To identify predictors of hypertension development and its impact on renal survival.
Main Methods:
- Retrospective analysis of 209 IgA nephropathy patients.
- Assessment of hypertension at renal biopsy and during follow-up.
- Survival analysis to determine renal survival rates.
Main Results:
- 45% of patients remained normotensive 10 years post-biopsy.
- Hypertension at biopsy correlated with poor prognosis markers.
- Similar markers predicted later hypertension development.
- Renal survival was 70% at 3 years post-hypertension diagnosis.
Conclusions:
- Hypertension is a critical factor influencing IgA nephropathy outcomes.
- Early identification of prognostic markers is crucial for managing patients.
- Hypertension management is essential for improving renal survival in IgA nephropathy.
Abstract:
We have studied 209 patients with IgA nephropathy. 26 were hypertensive at the time of renal biopsy, and 59 patients developed hypertension during follow-up. Survival statistics show that only 45% of the patients will remain normotensive 10 years after renal biopsy. The presence of hypertension at renal biopsy correlated well with the usual parameters of a poor prognosis. The same markers predicted a later development of hypertension in patients who were normotensive at the time of renal biopsy. When hypertension is established, the prognosis is poor. Three years after diagnosis of hypertension, the renal survival was found to be 70% in the 59 patients we have followed. It is also possible that the markers of a poor prognosis actually predict the progression rate rather than the prognosis, because in time, some patients with initially mild manifestations of the disease will progress to end-stage renal failure.